Gonorrhea-Blocking Mutation Also Protects Against Alzheimer’s: Study

Research traces the evolution of a gene variant that reduces the risk of Alzheimer’s disease, finding that it originally evolved in response to infectious bacteria.

Written byHolly Barker, PhD
| 4 min read
Artist’s rendition of multiple <em>Neisseria gonorrhoeae</em>, the bacteria that causes gonorrhea, depicted as two spheres stuck together, each covered in tendrils.
Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

In recent years, scientists have identified various naturally occurring mutations in the human genome that ward off Alzheimer’s disease. Now, in a study published July 9 in Molecular Biology and Evolution, researchers explain how one such gene variant initially emerged to protect against a different type of threat: gonorrhea.

According to the paper, a mutant form of an immune receptor, found in roughly one fifth of people, helps the immune system detect Neisseria gonorrhoeae, the bacteria responsible for the sexually transmitted disease. Typically, white blood cells particularly monocytes and macrophages, use a receptor called CD33, to distinguish between host cells and unwelcome pathogens invading the body. When CD33 binds to sialic acids—sugars that tend to adorn the membranes of host cells, acting as a molecular ID— immune cells recognize those cells and prevent the immune system from launching an attack.

But “bacteria are expressing sialic acid as a way to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Headshot of Holly Barker

    Holly Barker is a freelance writer based in London. She has a PhD in clinical neuroscience from King’s College London and a degree in biochemistry from the University of Manchester. She has previously written for Discover and Spectrum News.

    View Full Profile
Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas